2012
DOI: 10.1016/j.neuroscience.2011.11.013
|View full text |Cite
|
Sign up to set email alerts
|

Fever, sickness behavior, and expression of inflammatory genes in the hypothalamus after systemic and localized subcutaneous stimulation of rats with the toll-like receptor 7 agonist imiquimod

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
38
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(44 citation statements)
references
References 72 publications
5
38
1
Order By: Relevance
“…Similarly, only a modest sickness response was evidenced as a slight decrease in food and water intake but no change in overall LMA of rats (Damm et al, 2012). I have confirmed this and found a modest sickness response to imiquimod with mice (R.H.M., unpublished observations).…”
Section: Tlr3 Tlr7 Tlr8 and Tlr9: Nucleic Acidsmentioning
confidence: 55%
“…Similarly, only a modest sickness response was evidenced as a slight decrease in food and water intake but no change in overall LMA of rats (Damm et al, 2012). I have confirmed this and found a modest sickness response to imiquimod with mice (R.H.M., unpublished observations).…”
Section: Tlr3 Tlr7 Tlr8 and Tlr9: Nucleic Acidsmentioning
confidence: 55%
“…Fever is one of the most important signs of immune system activation, with an adaptive function that modifies the organism's internal environment to become unfavorable to the survival of pathogens [27,28,29,30]. After exposure to pathogens, a series of proinflammatory cytokines is produced by immune-competent cells, and various transcription factors are activated within the fever-controlling region of the hypothalamus.…”
Section: Discussionmentioning
confidence: 99%
“…This interpretation is backed up by the literature on "endogenous pyrogens" (Dinarello, 1999) and on imiquimod (Damm et al, 2012).…”
Section: Discussionmentioning
confidence: 96%
“…The first example is a low-molecular weight compound "imiquimod", a Tlr7 agonist, already on the market for treatment of skin viral infection (Hemmi et al, 2002). Subcutaneous injection of imiquimod was reported to induce fever, sickness behavior and induction of ISG in rats (Damm et al, 2012). The second example is a new polyfluoromethylated compound, 8-(1, 3,4-oxadiazol-2-yl)-2, 4-bis (trifluoromethyl) imidazo [1, 2-a] [1, 8] naphthyridine (RO4948191) which was reported to be an orally available low molecular weight interferon receptor agonist.…”
Section: Discussionmentioning
confidence: 99%